ISIS EIF4E Rx
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ISIS EIF4E Rx, covering 2018-06-27 to 2023-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC) [Phase 1, Phase 2]